PHM7 COST SIMULATION OF NOVOSEVEN VERSUS FEIBAAND ITT-F8 FOR PRIMARY PROPHYLAXIS TREATMENT OF HAEMOPHILIA A/B PATIENTS WITH INHIBITORS

Nov 1, 2007, 00:00
10.1016/S1098-3015(10)65034-6
https://www.valueinhealthjournal.com/article/S1098-3015(10)65034-6/fulltext
Title : PHM7 COST SIMULATION OF NOVOSEVEN VERSUS FEIBAAND ITT-F8 FOR PRIMARY PROPHYLAXIS TREATMENT OF HAEMOPHILIA A/B PATIENTS WITH INHIBITORS
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)65034-6&doi=10.1016/S1098-3015(10)65034-6
First page :
Section Title :
Open access? : No
Section Order : 193
Categories :
Tags :
Regions :
ViH Article Tags :